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Since the anti-inflammatory, antidiabetic and hypolipidemic effects of soy isoflavones may be mediated by activation of
peroxisome proliferator-activated receptors (PPAR), the present study investigated whether the methanolic fractions obtained
from soybean seeds (E1) and soybean seed coats with hypocotyls (E2) could influence PPARα, PPARγ and PPARβ/δ
transcriptional activity. The isoflavones from E1 and E2 were quantified by HPLC analysis. E1 and E2 were rich in isoflavones
(daidzin, glycitin, genistin, malonyldaidzin, malonylglycitin, malonylgenistin, daidzein, glycitein, and genistein). Moreover, E1
and E2 showed no evidence of genetically modified material containing the gene CP4 EPSPS. To investigate PPAR
transcriptional activity, human promonocytic U-937 cells were treated with E1 and E2 (200, 400, 800, and 1600 μg/mL), positive
controls or vehicle. Data are reported as fold-activation of the luciferase reporter driven by the PPAR-responsive element. Dose-
response analysis revealed that E1 and E2 induced the transcriptional activity of PPARα (P < 0.001), with activation comparable
to that obtained with 0.1 mM bezafibrate (positive control) at 1600 μg/mL (4-fold) and 800 μg/mL (9-fold), respectively. In
addition, dose-response analysis revealed that E1 and E2 activated PPARβ/δ (P < 0.05), and the activation at 800 μg/mL (4- and
9-fold, respectively) was comparable to that of 0.1 mM bezafibrate (positive control). However, no effect on PPARγ was
observed. Activation of PPARα is consistent with the lipid-lowering activity of soy isoflavones in vivo, but further studies are
needed to determine the physiological significance of PPARβ/δ activation.
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Introduction
Dietary soy has been shown to improve serum lipid
levels, glycemic control and atherosclerosis in many ani-
mal models of obesity and insulin resistance (1). Clinical
studies have also suggested the lipid-lowering effects of
soy protein consumption in humans (2). However, the
specific components of soy and the mechanisms underly-
ing these beneficial effects are still a matter of controversy
and remain to be identified (1).
Dietary soy components include protein, lipids, fiber,
and phytochemicals, such as isoflavones, which have
been identified as bioactive agents and widely recognized
as estrogen receptor agonists or phytoestrogens (3,4).
Although this activity has been implicated in the atheropro-
tective effects of isoflavones, it has been increasingly
accepted that these phytochemicals might activate other
nuclear receptors regulating lipid metabolism, such as
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liver x receptor, farsenoid x receptor and peroxisome pro-
liferator-activated receptors (PPARs) (1).
PPARs are members of the nuclear hormone receptor
superfamily of ligand-activated transcription factors and
regulate the expression of target genes involved in several
physiological processes (5). Three receptor subtypes have
been identified in mammals, namely PPARα, PPARβ/δ
and PPARγ, with overlapping tissue distribution and func-
tions. PPARα is expressed in high levels in the liver, kidney
and heart, PPARγ is largely expressed in adipose tissue
and PPARβ/δ is ubiquitously expressed (6).
PPARα controls the transcription of many genes in-
volved in the catabolism of lipids, and this explains its
hypolipidemic effects (7). Activation of PPARγ increases
insulin sensitivity and appears to be a favorable factor in
the treatment of insulin resistance associated with type 2
diabetes (8). In contrast to PPARα and PPARγ, the physi-
ological role of PPARβ/δ is not fully known (9). It has been
suggested that the anti-inflammatory, antidiabetic and hy-
polipidemic effects of soy isoflavones may be mediated by
activation of PPARα and PPARγ (10-12). However, little is
known about the possibility of activation of PPARβ/δ with
soy isoflavones. Therefore, in the present study, we inves-
tigated whether the methanolic fractions of soybean rich in
isoflavones could activate PPARβ/δ.
Material and Methods
Material
Soybean seeds and soybean seed coats with hypo-
cotyl fragments were obtained from the COAMO Company
(Brazil). The seed coats were obtained as an industrial
residue resulting from oil extraction from the seed. Isofla-
vone standards were purchased from Sigma (USA) and
Fuji Co. (Japan). Human promonocyte U937 cells were
obtained from Cells Culture Facility (University of Califor-
nia, USA). RPMI-1640 medium was obtained from Gibco
(USA). Lysis buffer and the kit for testing luciferase activity
were purchased from Promega (USA). Bezafibrate and
troglitazone were purchased from Sigma, and rosiglitazone
was purchased from Cayman Chemicals (USA). The ex-
pression vectors for PPARα, PPARαβ/δ and PPARαγ and
the plasmid containing the luciferase reporter driven by a
PPAR-responsive element were kindly provided by J.
Magae (Japan). The plasmid construction has been de-
scribed (13).
Analysis of transgenic soy
Genetically modified herbicide-tolerant soy varieties
contain the CP4 EPSPS gene that encodes 5-enol-
pyruvylshikimate-3-phosphate synthase from Agrobacte-
rium spp strain CP4. This gene confers resistance to
herbicides containing glyphosate. The presence of trans-
genic soybean was investigated using the Trait Crop and
Grain Testing kit from Strategic Diagnostics Inc. (USA), as
recommended by the manufacturer. Conventional non-
genetically modified soybean seeds and soybean seeds
containing the EPSPS gene were used as negative and
positive controls, respectively. Transgenic grains were
provided by the Monsanto Company (USA). These tests
were authorized by the National Technical Commission for
Biosafety (Certificate of Quality on Biosafety, CQB #0002/
96) and carried out at Embrapa Soybean (Brazil).
Extraction of isoflavones from soybean
One kilogram of frozen soybean seeds (E1) and soy-
bean seed coats with hypocotyl fragments (E2) were tritu-
rated and macerated with 12 L hexane for 20 days and
filtered. The residues E1 (702 g) and E2 (969 g) were
macerated with ethanol:water (3:2 v/v) for seven days and
filtered. The solvent from the extracts was evaporated
under reduced pressure and the lyophilized extract yielded
160.6 and 194.0 g ethanol extracts E1 and E2, respective-
ly. The ethanol extracts were mixed with 90 mL methanol
and centrifuged. The methanol fractions were evaporated
to provide 48.0 and 26.7 g of the methanol fraction of E1
and E2, respectively.
High-performance liquid chromatography
Isoflavones from both methanolic fractions (100 mg)
were extracted using a 70% water-ethanol solution (w/w)
containing 0.1% acetic acid at room temperature. Tubes
containing the samples were shaken every 15 min and
after 1 h the extracts (1.5 mL) were centrifuged at 14,000
rpm for 15 min at 5°C. The supernatant was then filtered
(0.45 μm) and 20 μL of each sample was used for high-
performance liquid chromatography (HPLC) analysis.
HPLC analysis of isoflavones was performed on an
ODS C18 column (YMC Pack ODS-AM 250 x 0.4 mm ID,
5.0 μm particle size, Japan) in a Waters 2690 HPLC
system with an auto sampler and a photodiode array
detector (Waters 996, USA). The wavelength was ad-
justed to 260 nm. A binary gradient solvent system was
employed. The mobile phases were: a) acidified methanol
(0.025% trifluoroacetic acid, TFA) and b) acidified Milli-Q
water (0.025% TFA). The initial composition of the gradient
was 20% solvent A system, reaching 100% A after 40 min,
and then returning to 20% A at 45 min and maintaining this
condition up to 60 min. The flow rate was 1 mL/min, with a
column temperature of 25°C. Isoflavones were adequately
separated within 60 min. Separated compounds were iden-
tified by comparison of retention times and UV spectra with
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isoflavone standards (glycoside and aglycon forms). Iso-
flavones were quantified using external standardization
method (peak areas), and molar extinction coefficient for
malonyl and acetyl forms (14).
Cell culture and transient transfection assays
Human promonocytic U-937 cells were maintained and
subcultured in RPMI-1640 medium (Invitrogen®, USA) sup-
plemented with 10% fetal bovine serum, penicillin (50 IU/
mL) and streptomycin (50 μg/mL), at 37°C and 5% CO2.
For transient transfection assays, cells were collected by
centrifugation and resuspended in phosphate-buffered
saline (PBS) containing calcium and dextrose (1.5 mL x
107 cells/0.5 mL PBS).
The cells were cotransfected with the expression vec-
tors for PPARα, -β/δ or -γ (1.5 μg) and a PPAR-responsive
luciferase reporter vector (DR1-TK-Luc) by electropora-
tion using a gene pulser (Bio-Rad®, USA) at 300 mV and
950 μF. Electroporated cells were then transferred to fresh
RPMI-1640 medium and plated onto 12-well dishes (1 mL/
well) and treated in triplicate with the methanolic fraction of
soybeans containing isoflavones (200, 400, 800, and 1600
μg/mL), bezafibrate (positive control for PPARα and -β/δ
transcriptional activity), troglitazone or rosiglitazone (posi-
tive control for PPARγ transcriptional activity) or vehicle
(ethanol/DMSO, 1:1). After 24 h, cells were collected by
centrifugation, lysed by the addition of 150 μL 1X lyses
buffer (Promega®, USA) and assayed for luciferase activity
using a Luciferase Assay Kit from Promega® and a
luminometer (Perkin Elmer®, USA).
Data are reported as fold-activation of the luciferase
reporter driven by the PPAR-responsive element calcu-
lated as the ratio of luciferase activity obtained in cell
samples treated with the different compounds divided by
luciferase activity obtained with vehicle. All experiments
were performed at least three times in triplicate.
Statistical analysis
The results of the transient transfection assays are re-
ported as means ± SEM. Statistical significance was deter-
mined by analysis of variance (ANOVA) followed by the
Newman-Keuls multiple comparison test, using the GraphPad
Prism software for Windows, version 3.0 (USA). A P value
<0.05 was considered to be statistically significant.
Results
Analysis of transgenic soy
Genetically modified soy containing the CP4 EPSPS
gene was not detected in any of the samples (data not
shown).
Analysis of the methanolic fractions of soybean seeds and
soybean seed coats with hypocotyls (HPLC-UV analysis)
The methanolic fractions of soybean seeds (Figure 1A)
and soybean seed coats and hypocotyls (Figure 1B) were
analyzed for isoflavone composition by HPLC using stand-
ard compounds for comparison. The isoflavone composi-
tion of both types of soy are given in Table 1. Most of the
isoflavones found in the soybean seeds were malonyl-
Figure 1. High-performance liquid chromatography (HPLC) pro-
file of the methanolic fractions of soybean seeds (A) and soy-
bean seed coats with hypocotyls (B). Compounds are: 1, daidzin;
2, glycitin; 3, genistin; 4, malonyldaidzin; 5, malonylglycitin; 6,
malonylgenistin; 7, daidzein; 8, glycitein; 9, genistein. Chromato-
graphic conditions: column Metasil ODS C18 (250 x 0.4 mm ID,
5.0 μm); linear gradient of methanol [0.025% TFA (solvent A)],
water [0.025% TFA (solvent B)], 0-40 min: 20-100% A, at a flow
rate of 1.0 mL/min; room temperature; injection 20 μL; detection:
260 nm. The concentration injected for methanolic fractions (A
and B) was about 66.6 mg/mL.
Table 1. Isoflavone composition of the methanolic fractions of
soybean seeds and seed coats with hypocotyls.
Soybean seeds Seed coats with hypocotyls
1. Daidzin 145.67 ± 3.14 393.78 ± 5.39
2. Glycitin 47.69 ± 1.86 149.41 ± 1.52
3. Genistin 147.54 ± 5.54 296.14 ± 4.14
4. Malonyldaidzin 276.54 ± 4.21 152.29 ± 3.38
5. Malonylglycitin 105.73 ± 1.17 89.11 ± 3.94
6. Malonylgenistin 466.54 ± 7.37 161.80 ± 2.82
7. Daidzein 57.73 ± 1.26 86.64 ± 0.93
8. Glycitein 22.61 ± 0.36 33.92 ± 1.08
9. Genistein 75.04 ± 1.61 55.84 ± 0.82
Total isoflavones 1345.09 1418.93
Data are reported as mg isoflavones in 100 g methanolic fraction
and as the means ± SD value of three determinations.
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Figure 2. Activation of peroxisome proliferator-activated recep-
tor alpha (PPARα) by the methanolic fraction of soybean seeds
(Panel A) or soybean seed coats with hypocotyls (Panel B). U-
937 cells were cotransfected with the expression vector for
PPARα receptor and a luciferase reporter and then treated with
vehicle (DMSO/ethanol, 1:1), bezafibrate or increasing amounts
of the methanolic fraction of soybean seeds or soybean seed
coats for 24 h and assayed for luciferase activity. Data are
reported as means ± SEM of fold-activation of PPARα. *P < 0.01
vs vehicle (one-way ANOVA followed by the Newman-Keuls
multiple comparison test).
Figure 3. Activation of peroxisome proliferator-activated receptor
gamma (PPARγ) by the methanolic fraction of soybean seeds
(Panel A) or soybean seed coats with hypocotyls (Panel B). U-
937 cells were cotransfected with the expression vector for the
PPARγ receptor and a luciferase reporter and then treated with
vehicle (DMSO/ethanol, 1:1), glitazone or increasing amounts of
the methanolic fraction of soybean seeds or soybean seed coats
for 24 h and assayed for luciferase activity. Data are reported as
means ± SEM of the fold-activation of PPARγ. *P < 0.01 vs
vehicle (one-way ANOVA followed by the Newman-Keuls mul-
tiple comparison test).
daidzin, malonylglycitin and malonylgenistin (Table 1). On
the other hand, most of the isoflavones found in the soy-
bean seed coats with hypocotyls were daidzin, glycitin and
genistin (Table 1).
Effect of increasing concentrations of a methanolic
extract rich in conjugated and non-conjugated soybean
isoflavones on PPARα transcriptional activity
Dose-response analysis revealed that the methanolic
fraction from soybean seeds and soybean seed coats with
hypocotyls induced the transcriptional activity of PPARα,
with activation comparable to that obtained with 0.1 mM
bezafibrate at 1600 μg/mL (Figure 2A) and 800 μg/mL
(Figure 2B), respectively.
Effect of increasing concentrations of a methanolic
extract rich in conjugated and non-conjugated soybean
isoflavones on PPARγ transcriptional activity
No activation of PPARγ was detected with any of the
concentrations tested of the methanolic fraction from soy-
bean seeds (Figure 3A) or with the methanolic fraction
from soybean seed coats with hypocotyls (Figure 3B). The
positive controls 10 μM troglitazone and 10 μM rosiglitazone
behaved as expected.
Effect of increasing concentrations of a methanolic
extract rich in conjugated and non-conjugated soybean
isoflavones on PPARβ/δ transcriptional activity
Dose-response analysis revealed that the methanolic
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fraction from soybean seeds activated PPARβ/δ, and the
activation at 800 μg/mL was comparable to that of 0.1 mM
bezafibrate (Figure 4A). Similar results were obtained with
800 μg/mL of the methanolic fraction from soybean seed
coats with hypocotyls (Figure 4B).
Discussion
The well-established beneficial effects of dietary soy
on lipid metabolism and insulin sensitivity have been re-
cently attributed to the activation of PPARα and PPARγ,
respectively, by soy isoflavones (1,8,10). However, little is
known about the possibility that isoflavones activate PPARβ/
δ, which plays a critical role in the regulation of metabolic
homeostasis, and also in cardiac lipid metabolism (15,16),
fetal development (17), inhibition of human cancer cell line
growth (18), protection against liver toxicity (19), modula-
tion of inflammation (6,20), and improved skeletal muscle
oxidative enzyme activity in obese patients with type 2
diabetes mellitus (21).
In the present study, a methanolic fraction from soy-
bean seeds and soybean seed coats with hypocotyls rich
in conjugated soybean isoflavones was used to address
the question of whether these soy fractions can activate
PPARβ/δ. For comparative purposes their effect on PPARα
and PPARγ was also investigated.
Our results indicated that the methanolic fractions rich
in conjugated soybean isoflavones induced PPARα and β/
δ transcriptional activity. Activation of PPARα has been
previously demonstrated in several other studies (10,11,12,
22). Unexpectedly, however, these fractions in the present
study did not induce PPARγ transcriptional activity. A pos-
sible explanation for this result certainly depends of future
studies with isolated isoflavones.
An important result is that the methanolic fractions rich
in conjugated and non-conjugated soybean isoflavones
used in this study activated PPARβ/δ. To the authors’
knowledge, this is the first demonstration that isoflavones
activate PPARβ/δ.
The effects of the methanolic fraction of soybean seeds
and soybean seed coats with hypocotyls on PPARα and
PPARαβ/δ transcriptional activity were similar although
their composition in general terms were different. It is
possible that the similar effects on both PPAR isoforms
could be due to comparable concentrations of the isofla-
vones genistein and daidzein in the methanolic fractions of
seeds and seed coats with hypocotyls. Further studies will
indicate which soy isoflavone or mixtures of isoflavones
activate PPARα and PPARβ/δ.
Taken together, our results are consistent with animal
and clinical studies addressing the potential of isoflavones
as lipid-lowering (8,10,11) and anti-inflammatory agents
(12), and it can be expected that the methanolic extract
from soybean seeds or seed coats with hypocotyls should
promote lipid-lowering and anti-inflammatory effects.
Moreover, the observation that the methanolic extract
from soybean seeds and from seed coats with hypocotyls
activated PPARα and PPARβ/δ but did not induce PPARγ
transcriptional activity is important in view of the potential
hepatotoxicity of PPARγ agonists. Furthermore, the possi-
bility that the anti-inflammatory effects of soy isoflavones
Figure 4. Activation of peroxisome proliferator-activated recep-
tor β/δ (PPARβ/δ) by the methanolic fraction from soybean seeds
(Panel A) or soybean seed coats with hypocotyls (Panel B). U-
937 cells were cotransfected with the expression vector for the
PPARβ/δ receptor and a luciferase reporter and then treated
with vehicle (DMSO/ethanol, 1:1), bezafibrate or increasing
amounts of the methanolic fraction of soybean seeds or soy-
bean seed coats for 24 h and assayed for luciferase activity.
Data are reported as means ± SEM of the fold-activation of
PPARβ/δ. *P < 0.05 vs vehicle (one-way ANOVA followed by the
Newman-Keuls multiple comparison test).
550
Braz J Med Biol Res 42(6) 2009
V.S. Carrara et al.
www.bjournal.com.br
(12) could be mediated by PPARβ/δ receptors (6) must be
considered. However, future in vivo studies will be neces-
sary to determine the physiological significance of activa-
tion of both PPARα and PPARβ/δ.
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